$1.10
+0.03 (+2.80%)
Open$1.06
Previous Close$1.07
Day High$1.12
Day Low$1.01
52W High$21.67
52W Low$13.58
Volume—
Avg Volume342.7K
Market Cap26.43M
P/E Ratio21.85
EPS$0.69
SectorN/A
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,317.3% upside
Current
$1.10
$1.10
Target
$15.59
$15.59
$14.04
$15.59 avg
$21.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.22M | 20.30M | 17.77M |
| Net Income | 1.18M | 1.16M | 1.21M |
| Profit Margin | 6.1% | 5.7% | 6.8% |
| EBITDA | 2.01M | 2.27M | 2.16M |
| Free Cash Flow | 1.07M | 1.22M | 952.2K |
| Rev Growth | +20.2% | +6.7% | +16.3% |
| Debt/Equity | 0.67 | 0.58 | 0.78 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |